相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Age-related shift in LTD is dependent on neuronal adenosine A2Areceptors interplay with mGluR5 and NMDA receptors
Mariana Temido-Ferreira et al.
MOLECULAR PSYCHIATRY (2020)
Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease
Chia-Chia Lee et al.
MOLECULAR NEUROBIOLOGY (2018)
Istradefylline reduces memory deficits in aging mice with amyloid pathology
Anna G. Orr et al.
NEUROBIOLOGY OF DISEASE (2018)
Blockade of adenosine A2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease
Antonio C. Silva et al.
NEUROBIOLOGY OF DISEASE (2018)
Long-term Treatment with Low-Dose Caffeine Worsens BPSD-Like Profile in 3xTg-AD Mice Model of Alzheimer's Disease and Affects Mice with Normal Aging
Raquel Baeta-Corral et al.
FRONTIERS IN PHARMACOLOGY (2018)
Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
Cyril Laurent et al.
BIOMEDICAL JOURNAL (2018)
Caffeine Reverts Memory But Not Mood Impairment in a Depression-Prone Mouse Strain with Up-Regulated Adenosine A2A Receptor in Hippocampal Glutamate Synapses
Nuno J. Machado et al.
MOLECULAR NEUROBIOLOGY (2017)
Targeted neurogenesis pathway-based gene analysis identifies ADORA2 Aassociated with hippocampal volume in mild cognitive impairment and Alzheimer's disease
Emrin Horgusluoglu-Moloch et al.
NEUROBIOLOGY OF AGING (2017)
Deletion of exons 9 and 10 of the Presenilin 1 gene in a patient with Early-onset Alzheimer Disease generates longer amyloid seeds
Kilan Le Guennec et al.
NEUROBIOLOGY OF DISEASE (2017)
Adenosine A2A receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation
Z-A Zhao et al.
TRANSLATIONAL PSYCHIATRY (2017)
How does adenosine control neuronal dysfunction and neurodegeneration?
Rodrigo A. Cunha
JOURNAL OF NEUROCHEMISTRY (2016)
Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond
Elise Cuyvers et al.
LANCET NEUROLOGY (2016)
ALTERED MOTILITY OF PLAQUE-ASSOCIATED MICROGLIA IN A MODEL OF ALZHEIMER'S DISEASE
Stefka Gyoneva et al.
NEUROSCIENCE (2016)
Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors
Silvia Viana da Silva et al.
NATURE COMMUNICATIONS (2016)
A(2A) adenosine receptor deletion is protective in a mouse model of Tauopathy
C. Laurent et al.
MOLECULAR PSYCHIATRY (2016)
An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity
Jing Lu et al.
PLOS ONE (2016)
The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function
Vania L. Batalha et al.
SCIENTIFIC REPORTS (2016)
PART is part of Alzheimer disease
Charles Duyckaerts et al.
ACTA NEUROPATHOLOGICA (2015)
Deletion of Adenosine A2A Receptors From Astrocytes Disrupts Glutamate Homeostasis Leading to Psychomotor and Cognitive Impairment: Relevance to Schizophrenia
Marco Matos et al.
BIOLOGICAL PSYCHIATRY (2015)
Nuclear Receptors License Phagocytosis by Trem2+ Myeloid Cells in Mouse Models of Alzheimer's Disease
Julie C. Savage et al.
JOURNAL OF NEUROSCIENCE (2015)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
Optogenetic activation of intracellular adenosine A2A receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory
P. Li et al.
MOLECULAR PSYCHIATRY (2015)
Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory
Anna G. Orr et al.
NATURE NEUROSCIENCE (2015)
Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress
Manuella P. Kaster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory
Elodie Marciniak et al.
SCIENTIFIC REPORTS (2015)
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
Vanessa Flaten et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology
Cyril Laurent et al.
NEUROBIOLOGY OF AGING (2014)
Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease
Stefka Gyoneva et al.
NEUROBIOLOGY OF DISEASE (2014)
Hydrogen Sulfide Inhibits A2A Adenosine Receptor Agonist Induced β-Amyloid Production in SH-SY5Y Neuroblastoma Cells via a cAMP Dependent Pathway
Bhushan Vijay Nagpure et al.
PLOS ONE (2014)
Munc18-1 is a dynamically regulated PKC target during short-term enhancement of transmitter release
Oezguer Genc et al.
ELIFE (2014)
Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation
V. L. Batalha et al.
MOLECULAR PSYCHIATRY (2013)
Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like Pathology
Grietje Krabbe et al.
PLOS ONE (2013)
NTPDase1 activity attenuates microglial phagocytosis
Larisa Bulavina et al.
PURINERGIC SIGNALLING (2013)
A1R-A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes
Sofia Cristovao-Ferreira et al.
PURINERGIC SIGNALLING (2013)
Analysis of differential plaque depositions in the brains of Tg2576 and Tg-APPswe/PS1dE9 transgenic mouse models of Alzheimer disease
Tae-Kyung Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2012)
Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes
Marco Matos et al.
GLIA (2012)
Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease
Wei Zhang et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction
Nelson Rebola et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Epidemiology of Alzheimer disease
Christiane Reitz et al.
NATURE REVIEWS NEUROLOGY (2011)
At the junction of SNARE and SM protein function
Chavela M. Carr et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX
Lyndsey E. Collins et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Caffeine Suppresses Amyloid-β Levels in Plasma and Brain of Alzheimer's Disease Transgenic Mice
Chuanhai Cao et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice
Gary W. Arendash et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Adenosine A2A Receptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by β-Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway
Paula M. Canas et al.
JOURNAL OF NEUROSCIENCE (2009)
Adenosine A2A receptor mediates microglial process retraction
Anna G. Orr et al.
NATURE NEUROSCIENCE (2009)
Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A2A receptor knockout mice with microarray profiling
Liqun Yu et al.
PHYSIOLOGICAL GENOMICS (2009)
Munc18=1 in secretion: lonely Munc joins SNARE team and takes control
Ruud F. G. Toonen et al.
TRENDS IN NEUROSCIENCES (2007)
β-amyloid pathology in the entorhinal cortex of rats induces memory deficits:: Implications for Alzheimer's disease
E. Sipos et al.
NEUROSCIENCE (2007)
Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice
Oscar P. Dall'Igna et al.
EXPERIMENTAL NEUROLOGY (2007)
Working memory deficits in transgenic rats overexpressing human adenosine A(2A) receptors in the brain
Lydia Gimenez-Llort et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2007)
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
Monica Garcia-Alloza et al.
NEUROBIOLOGY OF DISEASE (2006)
Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain β-amyloid production
G. W. Arendash et al.
NEUROSCIENCE (2006)
Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease:: Relationships to β-amyloid deposition and neurotransmitter abnormalities
A Savonenko et al.
NEUROBIOLOGY OF DISEASE (2005)
Enhanced adenosine A2A receptor facilitation of synaptic transmission in the hippocampus of aged rats
N Rebola et al.
JOURNAL OF NEUROPHYSIOLOGY (2003)
Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics
D Blum et al.
LANCET NEUROLOGY (2003)
Neuroprotection by caffeine and adenosine A2A receptor blockade of β-amyloid neurotoxicity
OP Dall'lgna et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse
RT Sasmono et al.
BLOOD (2003)
Amyloid precursor protein, presenilins, and α-synuclein:: Molecular pathogenesis and pharmacological applications in Alzheimer's disease
YH Suh et al.
PHARMACOLOGICAL REVIEWS (2002)
A new neuromodulatory pathway with a glial contribution mediated via A2a adenosine receptors
T Nishizaki et al.
GLIA (2002)
Hippocampal Aβ42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice
J Puoliväli et al.
NEUROBIOLOGY OF DISEASE (2002)
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies
JL Jankowsky et al.
BIOMOLECULAR ENGINEERING (2001)
Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A2A-selective adenosine receptor antagonists
R Sauer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)